SNDL Inc. (NasdaqCM: SNDL)
Health Care · Pharmaceuticals · CA
$1.18
-3.69% today · -50.8% 1Y
SNDL Inc. (NasdaqCM: SNDL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $303.37M and employs 2,751 people.
Over the last twelve months the share price has lost 50.8%, trading between 1.17 and 2.84.
Tweenvest scores SNDL Inc. across four factors: quality 63/100, value 69/100, growth 8/100. Its strongest factor is value.
SNDL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $303.37M
- Revenue (TTM)
- $653.75M
- P/E
- —
- EPS
- -0.08
- Dividend yield
- —
- Beta (5Y)
- 0.93
- 52-week high
- $2.84
- 52-week low
- $1.17
- Avg volume (3M)
- —
- Shares outstanding
- 248.66M
- Employees
- 2,751
- Next earnings
- —
About SNDL Inc.
SNDL Inc. is a Canadian firm engaged in the cultivation, distribution, and sale of cannabis products across the country. Its operations are organized into two distinct segments: Cannabis Operations and Retail Operations. Through its Cannabis Operations, the company manages the growing, supplying, and selling of cannabis specifically for the adult-use market. Meanwhile, its Retail Operations segment is responsible for the direct private sale of recreational cannabis via a network of both corporate-owned and franchised retail outlets. SNDL also produces and distributes a range of inhalable cannabis products, including dried flower, pre-rolled joints, and vape cartridges. These items are marketed under several key brands, such as Top Leaf, Sundial Cannabis, Palmetto, and Grasslands. The company, originally incorporated in 2006 as Sundial Growers Inc., officially adopted its current name, SNDL Inc., in July 2022. Its main corporate office is situated in Calgary, Canada.
- ISIN
- CA83307B1013
- Founded
- 2006
- Listed since
- Aug 1, 2019
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Standard Chemical & Pharmaceutical Co., Ltd.TWSE: 1720 | $317.99M | NT$56.90 | +1.43% |
| Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,LtdSZSE: 301130 | $316.94M | CN¥28.12 | -1.37% |
| Shukra Pharmaceuticals LimitedBSE: 524632 | $304.29M | Rs66.99 | +8.33% |
| Guiyang Xintian Pharmaceutical Co.,Ltd.SZSE: 002873 | $303.47M | CN¥8.55 | +2.03% |
| EI- Nile Co. for Pharmaceuticals and Chemical IndustriesCASE: NIPH | $301.23M | EGP315.50 | -4.69% |
| Biofarm S.A.BVB: BIO | $299.92M | RON— | — |
| Zhejiang Benli Technology Co., Ltd.SZSE: 301065 | $297.77M | CN¥19.88 | -0.90% |
| Bukwang Pharmaceutical Co., Ltd.KOSE: A003000 | $297.60M | ₩4,055.00 | -1.10% |
Figures last refreshed Oct 11, 2026.